Cleared Traditional

K023920 - SKINTACT

K023920 is an FDA 510(k) clearance for SKINTACT, manufactured by Leonhard Lang GmbH. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K023920 · Leonhard Lang GmbH · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2003
Decision
52d
Days
Class 2
Risk

K023920 is an FDA 510(k) clearance for the SKINTACT. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Leonhard Lang GmbH (Stillwater, US). The FDA issued a Cleared decision on January 16, 2003 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K023920

510(k) Number K023920 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 2002
Decision Date January 16, 2003
Days to Decision 52 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 125d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 235
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K023920.
BODY SIGNAL ECG ELECTRODE
K031174 · Wandy Rubber Industrial Co., Ltd. · Jul 2003
VERMED A10021 RESTING EKG TAB ELECTRODE
K030073 · Vermont Medical, Inc. · Mar 2003
SKINTACT ECG TAB ELECTRODE
K030509 · Leonhard Lang GmbH · Mar 2003
SKINTACT ECG ELECTRODES WITH KL 02 LIQUID GEL
K024247 · Leonhard Lang GmbH · Jan 2003
SKINTACT
K024264 · Leonhard Lang Co. · Jan 2003
NIKOMED TRACE 1 ECG ELECTRODES
K022909 · Nikomed U.S.A., Inc. · Jan 2003
K023920 · SKINTACT
Download PDF FDA Summary Leonhard Lang GmbH